LINC01335

Across TCGA pan-cancer cohorts, LINC01335 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated LINC01335 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC01335 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01335 expression acts as an unfavorable survival marker, although some lineages such as ESCA and SARC show a favorable association.

ACC, UCEC, and READ are the cancer types where LINC01335 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.145	0.888	<.001	135	view →
UCEC	OS	Tertile	All	0.640	0.880	<.001	114	view →
READ	OS	Tertile	II,III,IV	0.111	0.919	<.001	108	view →
CESC	OS	Tertile	All	0.617	0.883	<.001	108	view →
HNSC	DFS	Tertile	II,III,IV	0.359	0.624	.005	57	view →
KIRP	OS	Tertile	II,III,IV	0.161	0.783	<.001	48	view →
STAD	DFS	Tertile	All	0.225	0.542	<.001	45	view →
ESCA	DFS	Tertile	III,IV	0.642	0.238	.002	36	view →
THCA	DFS	Tertile	II,III,IV	0.768	0.934	.004	33	view →
LUSC	OS	Tertile	III,IV	0.117	0.717	.004	27	view →
KIRC	DFS	Tertile	All	0.305	0.651	.008	12	view →
SKCM	OS	Tertile	II,III,IV	0.606	0.847	.012	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

LINC01335–ACC (OS)

Open the ACC breakdown →